SCHEMBL16092276

SCHEMBL16092276

CC(C)c1c(-c2cnn(Cc3cccnc3)c2)[nH]c2c(C#N)cnn2c1=O

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM5B Q9UGL1 6/20 0.53
KDM5A P29375 9/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
CREBBP Q92793 2/20 0.36
KDM5C P41229 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
ADORA2B P29275 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16092313 0.91 KDM5B (0.50) KDM5BKDM5AL3MBTL1CREBBPADORA2B
SCHEMBL17547793 0.90 KDM5B (0.51) KDM5BKDM5ACREBBPKDM5CADORA2B
SCHEMBL16092356 0.86 KDM5B (0.46) KDM5BKDM5AL3MBTL1CREBBPKDM5C
SCHEMBL17547800 0.86 KDM5B (0.44) KDM5BKDM5AL3MBTL1CREBBPKDM5C
SCHEMBL16092484 0.86 ADORA2B (0.45) KDM5BKDM5ACREBBPKDM5CADORA2B
SCHEMBL16092494 0.86 ADORA2B (0.48) KDM5BCREBBPADORA2BADORA3ADORA2A
SCHEMBL16092324 0.85 CREBBP (0.44) KDM5BKDM5ACREBBPKDM5CADORA2B
SCHEMBL16092235 0.85 KDM5A (0.53) KDM5BKDM5AKDM5CKDM4CKDM4E
SCHEMBL17547791 0.84 ADORA2B (0.46) KDM5BKDM5ACREBBPKDM4CADORA2B
SCHEMBL16092353 0.84 KDM5A (0.40) KDM5BKDM5ACREBBPKDM5CKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 US disclosed
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 US disclosed
WO-2015135094-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2015-09-17 WO disclosed
WO-2014139326-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2014-09-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035801-B2 Pyrazolo compounds and uses thereof KDM5A, KDM5C, KDM5B KDM5B 3/4885KDM5A 1/4885L3MBTL1 2420/4885
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF KDM5A, KDM5C, KDM5B KDM5B 3/4885KDM5A 1/4885L3MBTL1 2420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.